Strattera and Medrol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Strattera (atomoxetine hydrochloride) and Medrol (methylprednisolone). Common drug interactions include headache among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Strattera and Medrol. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,323 Strattera users. Check the latest studies of Strattera.

What is Medrol?

Medrol has active ingredients of methylprednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 24,443 Medrol users. Check the latest studies of Medrol.

On Jul, 13, 2026

15 people who take Strattera and Medrol together, and have interactions are studied.

What are the common drug interactions of Strattera and Medrol, by gender? *:

female:

Headache (pain in head)
Diarrhoea
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Anaemia (lack of blood)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hypoaesthesia (reduced sense of touch or sensation)
Polycythaemia (proportion of blood volume that is occupied by red blood cells increases)
Rash
Sensation of foreign body

male:

Anxiety
Aggression
Fatigue (feeling of tiredness)
Joint injury
Loss of libido (loss of sexual urge)
Mood swings (an extreme or rapid change in mood)
Osteoarthritis (a joint disease caused by cartilage loss in a joint)
Osteoporosis (bones weak and more likely to break)
Pain
Renal disorder (kidney disease)

What are the common drug interactions of Strattera and Medrol, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Erythema (redness of the skin)
Nasopharyngitis (inflammation of the nasopharynx)

20-29:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Back pain
Bone density decreased
Cough
Emotional distress
Feeling hot
Flushing (the warm, red condition of human skin)
Infusion related reaction
Joint injury

30-39:

Hypoaesthesia (reduced sense of touch or sensation)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Rash
Sensation of foreign body
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)

40-49:

Headache (pain in head)
Irritability
Mood swings (an extreme or rapid change in mood)
Sluggishness (lacking alertness)
Somnolence (a state of near-sleep, a strong desire for sleep)
Diarrhoea
Anaemia (lack of blood)
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Vitamin d deficiency

50-59:

Pancreatic carcinoma stage ii (pancreatic cancer stage ii)

60+:

n/a

What are the existing conditions these people have? *

Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 40.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 40.00%
Drowsiness: 4 people, 26.67%
Pain: 3 people, 20.00%
Type 2 Diabetes: 1 person, 6.67%
Hiv Infection: 1 person, 6.67%
Allergic Rhinitis: 1 person, 6.67%
Back Pain: 1 person, 6.67%
Breast Cancer: 1 person, 6.67%
Cough: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and Medrol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously